Sary Alsanea

Sary Alsanea, RPh, IFCE, PMP, PhD, currently serves on the Advisory Committee for the Quality of Marketed Pharmaceutical and Biopharmaceutical Products at SFDA since June 2025. At King Saud University, Sary has held multiple roles since February 2020, including Supervisor of the Initiatives Management Office, Head of the Strategy Management Unit, and Advisor for the KSU Distinguished and Talented Students Program. As an Associate Professor of Pharmacology and Toxicology at the College of Pharmacy, Sary also directs the Project Management Office and contributes to the College Council. Additionally, Sary is a Co-Founder and Board member of the Digital Health Awareness Society, serves as a member of the GCC Board Directors Institute, and has previous editorial experience with the Saudi Pharmaceutical Journal. Educational qualifications include a PhD in Pharmaceutical and Biomedical Sciences from The University of Georgia and a BS in Pharmaceutical Sciences from King Saud University.